Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Nastroon Feb 28, 2019 2:39pm
70 Views
Post# 29424519

RE:Page 28

RE:Page 28That's a very good point Growth I've thought about it a lot myself as to why it's not got a much bigger market cap.  The main reasons I can come up with are:
  • It's on the wrong exchange.  Should be on NASDAQ, many US investors don't like the TSX-V and the OTC.  
  • Its a 'one trick pony' as it's  only got one product
  • This is their first product bought to market so they have no previous track record of success.
  • It has not yet had FDA approval and therefore if it fails there's nothing else out there so many will wait until it's cleared this hurdle.
  • its very small and therefore too illiquid for many and just too far below the radar for most.
For what it's worth I can't see it not getting FDA approval and I fully expect it to sell very well.  However, the risk is primarily in the sales and marketing in my opinion.  When I ran a comparison between CVR and Helius I had it coming out at between 12 to 15 times the size in market cap terms.  Still only time will tell on that and as I said all in my opinion.

Bullboard Posts